Pulse Biosciences, Inc.
PLSE· Nasdaq
Filed May 11, 2020 · 10-Q · 41 days after period end · 0001625101-20-000027
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$11.87M | -$10.08M | -$8.67M | -$3.20M |
| EPS Diluted | -$0.57 | -$0.49 | -$0.51 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 11, 2020 · 41 d after period end